Existing methods of COVID-19 testing can be time consuming and often uncomfortable for patients.
Researchers at McMaster University are collaborating with medical-device company Picomole Inc. to use infrared spectrometry to investigate how volatile organic compounds in exhaled breath can be used to rapidly and non-invasively detect the virus. The team is collecting breath samples from COVID-19 patients using Picomole’s proprietary breath analytics technology to distinguish COVID-19 patients from controls.
The success of the project would create broad implementation of breath analytics testing to facilitate early detection of COVID-19 cases to inform more accurate public health and policy decisions.
For more information, visit McMaster University.
